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Brief report
Measurement of spleen volume by ultrasound scanning in patients
with thrombocytosis: a prospective study
Marco Picardi, Vincenzo Martinelli, Rosanna Ciancia, Ernesto Soscia, Roberto Morante, Antonio Sodano,
Giuliana Fortunato, and Bruno Rotoli
Spleen size was assessed in 73 patients
with thrombocytosis and in 15 healthy
subjects, comparing palpation with ultra-
sonography (US) measurement of longitu-
dinal diameter and volume. Intraobserver
and interobserver variability for volume
on US, checked in 12 patients, was very
low. Correlation between spleen volume
measured by US and that measured by
computed tomography was excellent.
Splenomegaly was detected by palpation
in 25% of patients, by US assessment of
longitudinal diameter in 33%, and by US
assessment of volume in 52%. After diag-
nostic work-up, 54 patients had a diagno-
sis of essential thrombocythemia (ET), 4
of idiopathic myelofibrosis (IMF), and 15
of secondary thrombocytosis (ST). Spleen
volume in patients with ST was in the
normal range (138  47 mL) and was sig-
nificantly lower than that in patients with
ET or IMF (370  210 mL; P < .001). Thus,
US-measured volume was the most sensi-
tive method for identifying nonpalpable
splenomegaly in patients with primary my-
eloproliferative diseases, and it may help in
distinguishing these diseases from reactive
disorders. (Blood. 2002;99:4228-4230)
© 2002 by The American Society of Hematology
Introduction
Enlargement of the spleen is an important criterion in diagnosing
primary myeloproliferative diseases.1-3 Because splenomegaly may
occur in patients in whom the spleen is not palpable, the most
sensitive imaging procedure for measuring splenic size has been
sought. Nuclear medicine techniques, which are relatively complex
and not routinely available, expose patients to radiation.4-6 One-
dimensional ultrasonography (US) is often inaccurate.7 Computed
tomography (CT) and magnetic resonance imaging are relatively
expensive. Thus, stringent criteria for defining splenomegaly by
using imaging methods are still controversial.1-7 We tested the
accuracy of US-measured spleen volume compared with palpation
and US-measured longitudinal diameter in detecting splenomegaly
in patients with thrombocytosis subsequently classified as having
myeloproliferative diseases or reactive conditions. We used a group
of healthy subjects to establish reference ranges for US volume and
a patient subgroup to assess variability in US measurements and
examine the correlation between US-measured and CT-measured
spleen volume.
Study design
In the past 3 years, we prospectively studied 73 consecutive patients (43
women and 30 men; median age, 50 years [range, 13-75 years]; median
body-surface area, 1.7 m2 [range 1.4-2.0 m2]) who presented with
thrombocytosis (median platelet count, 720  109/L; range, 600-
1898  109/L) of unknown origin. Patients with overt spleen enlarge-
ment (ie, 3 cm from the costal border at palpation) or with a disease
associated with splenomegaly (eg, portal hypertension or thalassemia)
were excluded from the study. Informed consent to participation was
obtained from all subjects studied.
All spleen US scans were performed by the same operator, who used
an EUB 525 Hitachi (Tokyo, Japan) instrument with a 2.5/3.5-MHz
broadband curvilinear probe. The spleen was scanned in patients who
were fasting, in the longitudinal and transverse planes by using an
intercostal approach, a subcostal approach, or both. The patient was
placed in a supine or right-sided position until complete organ visualiza-
tion was achieved.8-10 Perimeter, longitudinal diameter, and area,
defined as the maximum measurements with splenic borders and angles
clearly defined, were measured, and volume (in milliliters) was calcu-
lated automatically. Reference values for volume were obtained from
measurements in 15 healthy subjects matched with the patients for sex,
age, and body-surface area. For each subject, the mean value of 3
measurements repeated on the same occasion was calculated and
recorded for final analysis.
Twelve unselected patients were studied by repeated US measure-
ments on 2 occasions at a 1-week interval by the same operator
(intraobserver reproducibility) and by another operator unaware of the
previous results, with both operators using the same US machine
(interobserver reproducibility).11,12 After informed consent to participa-
tion was obtained again, the same 12 patients underwent a CT
examination. Spleen axial images were obtained by using a multirow
helical instrument (Mx 8000; Marconi Medical Systems, Cleveland,
OH), to produce a 3-dimensional model used to calculate volumes
automatically.13 Technical parameters included 6.5-mm slice width with
identical reconstruction index, pitch 1, 200 mA, 120 kilovolt potential,
and a rotation time of 0.75 seconds.
All patients underwent physical examination, full blood counts,
assessment of blood smears and serum ferritin levels, and a search for
possible causes of reactive thrombocytosis. Morphologic, cytogenetic,
and molecular studies of bone marrow aspirates and a trephine biopsy
with use of the Perls reaction for iron deposits and the silver-
impregnation method for grading reticulin fibrosis were performed in all
nonsecondary cases. In accordance with the updated criteria of the
Polycythemia Vera Study Group,1,2 54 patients were found to be affected
by essential thrombocythemia (ET), 4 by idiopathic myelofibrosis
(IMF), and 15 by secondary thrombocytosis (ST) due to inflammatory
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conditions, iron-deficiency anemia, amyloidosis, or metastasizing malig-
nant disease.
Statistical evaluations, including 2 testing, analysis of variance with
Bonferroni correction, and Pearson correlation, were performed with SPSS
for Windows software (version 9.0; SPSS, Chicago, IL).
Results and discussion
Intraobserver reproducibility and interobserver reproducibility of
measurements of spleen volume by US were excellent, with
Pearson values of 0.999 and 0.997, respectively. Spleen-volume
measurements by US and by CT scanning were strongly correlated,
with a Pearson value of 0.945 (P  .001).
In the healthy subjects, spleen longitudinal diameter ranged
from 8 to 11 cm (median, 9.5 cm) and spleen volume from 60 to
200 mL (median, 140 mL). Among the 73 patients studied, spleen
enlargement was detected by palpation (between 0.5 and 2 cm
below the costal margin) in 18, by US assessment of longitudinal
diameter in 24, and by US assessment of volume in 38. A Pearson
value of 0.407 indicated a clear disagreement between the volume
and longitudinal-diameter measurements. Measurement of volume
had significantly higher sensitivity in detecting splenomegaly
compared with measurement of longitudinal diameter and palpa-
tion (52% versus 33% or 25%; P  .003). Of the 54 patients with
ET, 16 (29%) had palpable splenomegaly, 22 (40%) had increased
longitudinal diameter on US, and 34 (63%) had volume enlarge-
ment on US (overall median, 320 mL; range, 81-1000 mL). The
difference in median spleen volume between patients with ET and
healthy subjects was significant (P  .001). All 4 patients with
IMF had marked spleen-volume enlargement (median, 670 mL;
range 510-1000 mL), whereas only 2 of them had splenomegaly on
palpation or US assessment of longitudinal diameter. In the group
with ST, spleen-volume estimation by US was in the normal range
(median, 110 mL).
In a preliminary analysis, we stratified the patients in the ET
cohort according to US-measured spleen volume. Twenty patients
with a normal volume ( 200 mL) had a median serum lactic
dehydrogenase (LDH) level of 350 U/L (range, 200-509 U/L;
normal value, 227-450 U/L) and no or mild bone marrow fibrosis;
18 patients with a spleen volume between 246 and 490 mL had a
median LDH level of 452 U/L (range, 360-774 U/L), with mild to
moderate bone marrow fibrosis in 11; and 16 patients with a spleen
volume at least 500 mL had a median LDH level of 462 U/L (range,
200-748 U/L), with mild to moderate bone marrow fibrosis in 14.
In 2 patients in the latter group, IMF developed after a median
follow-up time of 12 months, whereas none of the patients in the
other groups had onset of IMF after a median follow-up time of 18
months. Moreover, patients with ET and a spleen volume at least
500 mL had less response to a first-line interferon treatment; only
one of the 5 patients in this group had normalization of platelet
counts, compared with 11 of 14 patients in the groups with no to
moderate ( 500 mL) spleen-volume enlargement.
In conclusion, in contrast to other studies employing different
methods,5-7 we found a high rate of splenomegaly in patients with
ET by using US measurements of volume (Figure 1). These
findings are consistent with those of another series, in which spleen
volume was measured by a radionuclide technique (single-photon
emission CT).4 Because the spleen is an irregularly shaped organ
that may enlarge at different rates in its various dimensions,
physical examination1-3 and imaging using one-dimensional mea-
surements5-7 may underestimate the true organ size, thus suggesting
Figure 1. Spleen volume in healthy subjects and in patients with thrombo-
cytosis. Spleen volume was measured by US in healthy control subjects (NCS) and
in patients with secondary thrombocytosis (ST), essential thrombocythemia (ET), or
idiopathic myelofibrosis (IMF).
Figure 2. Various spleen shapes detected by US. (A) Spleen in a control subject
having normal longitudinal diameter and volume. (B) Spleen in a thrombocythemic
patient having longitudinal diameter like that in Figure 2A but clearly enlarged volume.
(C) Spleen in a control subject showing enlarged longitudinal diameter but normal
volume (rodlike spleen).
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an erroneously low incidence of splenomegaly in patients with ET.
Multidimensional US spleen-volume measurement (defined as the
integration of longitudinal diameter, perimeter, and area) is a rapid,
reliable, and low-cost method for detecting the true spleen size
(Figure 2). In addition, our data support the concept of clinical
heterogeneity in patients with ET3,14,15; a role for spleen-volume
measurement in subgrouping these patients will be better evaluated
by studies in progress.
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